Infoscience

Patent

Inhibition of S6 Kinase activity for the treatment of insulin resistance

This invention provides screening methods for agents effective in treating insulin resistance through specific inhibition of S6 kinase 1 activity. Also provided are methods of treating insulin resistance by administering an effective amount of an inhibitor specific for S6 kinase 1

    Note:

    Applicant(s): Novartis Forschungsstiftung [CH]

    Reference

    Record created on 2009-04-20, modified on 2016-08-08

Fulltext

  • There is no available fulltext. Please contact the lab or the authors.

Related material